Co-proxamol (Dextropropoxyphene hydrochloride/paracetamol) - Pain
You are here : Home > Formulary Search > Co-proxamol (Dextropropoxyphene hydrochloride/paracetamol) - Pain
Status 1
- Not Specified
Documentation
PAD Profile
No longer licensed because of safety concerns, particularly toxicity in overdose.
Listed in 'Items which should not routinely be prescribed in primary care: policy guidance'. Click drug name for details.
Committee Recommendations (1)
The Prescribing Clinical Network does not recommend the use of co-proxamol. Co-proxamol will be considered NON-FORMULARY on the traffic light system. Prescribers should: - NOT initiate co-proxamol for any new patient AND - Switch patients taking co-proxamol to an alternative pain medication, in line with NHS England guidance.
Other Indications
Below are listed other indications that Co-proxamol (Dextropropoxyphene hydrochloride/paracetamol) is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Pain .
- Alfentanil hydrochloride
- Aspirin
- Buprenorphine
- Cannabis (medicinal)
- Co-codamol
- Co-dydramol 10/500
- Co-dydramol 20/500
- Co-dydramol 30/500
- Codeine phosphate
- Diamorphine hydrochloride
- Dihydrocodeine tartrate
- Fentanyl
- Gabapentin
- Ibuprofen
- Ketamine
- Meptazinol hydrochloride
- Methoxyflurane
- Morphine sulfate
- Nefopam hydrochloride
- Oxycodone
- Oxycodone with naloxone
- Paracetamol
- Pethidine hydrochloride
- Pregabalin
- Sufentanil
- Tramadol hydrochloride
- Tramadol with Dexketoprofen
- Tramadol with paracetamol
- Ziconotide acetate